The EU fined Illumina the equivalent of about $476 million for proceeding with its acquisition of cancer-test developer Grail before the bloc’s antitrust watchdog decided whether to approve the deal.

The EU fined Illumina the equivalent of about $476 million for proceeding with its acquisition of cancer-test developer Grail before the bloc’s antitrust watchdog decided whether to approve the deal. https://ift.tt/NBCaLXT